Luiz Gonzaga Vaz Coelho is an expert in Gastroenterology at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (Brazil). Luiz Gonzaga Vaz Coelho has authored 72 publications, the most recent in 2026. SLR score: 220 (community average: 125). How the SLR is computed.

LeadR Profile

220 ScienceLeadR Reputation 220
Network Map

Gastroenterology

Subspecialties: Infectiology - Pharmacy - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1978 - 2026

Source: PubMed

Universidade Federal de Minas Gerais

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 72

Citations

Citations: 1 088 1st author: 21 Last author: 19 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
VTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION.
PMID 42585493 — helicobacter pylori, gastroenterology, helicobacter, neoplasms, therapeutics, stomach neoplasms, infections
Arq Gastroenterol20260
HELICOBACTER PYLORI BEYOND THE STOMACH: WHEN THE STORY CHANGES.
PMID 42484112 — helicobacter pylori, stomach, gastroenterology, helicobacter, stomach diseases, infections
Arq Gastroenterol20260
Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.
PMID 42310251 — helicobacter pylori, helicobacter, antimicrobial stewardship, pharmacology, therapeutics, drug resistance
Aliment Pharmacol Ther20264
Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer.
PMID 41400466 — cells, biological science disciplines, neoplasms, biopsy, biomarkers, biomarkers, tumor, therapeutics, dna, liquid biopsy, stomach neoplasms, prognosis
Elife20250
Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp-BrazilReg).
PMID 41088538 — registries, levofloxacin, helicobacter pylori, metronidazole, amoxicillin, helicobacter, treatment failure, tetracycline, retreatment, therapeutics, infections, helicobacter infections
Helicobacter20250

LeadR Networks

Main global connection map